Increased eyelid pigmentation associated with use of latanoprost - 05/09/11
Abstract |
PURPOSE: To report increased eyelid pigmentation as an adverse side effect associated with topical latanoprost.
METHOD: Case report. A 62-year-old Korean woman with normal-tension glaucoma developed bilateral increased eyelid skin pigmentation 4 months after beginning treatment with latanoprost in both eyes. Clinical examinations were performed, and external photographs were taken.
RESULT: Latanoprost was discontinued. Periodic examinations revealed that the eyelid skin pigmentation gradually diminished 1 month after the cessation of the drug, and decrease in pigmentation continued over 4 months of follow-up.
CONCLUSION: An increase in eyelid skin pigmentation is a possible complication of topical latanoprost therapy, and the cessation of the drug can result in loss of induced pigmentation in humans.
Le texte complet de cet article est disponible en PDF.Plan
Vol 129 - N° 6
P. 804-806 - juin 2000 Retour au numéro
Article précédent
- Aspergillus flavus keratitis after laser in situ keratomileusis
- M.S Sridhar, Prashant Garg, Aashish K Bansal, Usha Gopinathan
- Posterior subcapsular cataract in Degos disease
- Robert Egan, Simmons Lessell
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?